Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Biosimilars Council Urges Global Comparators And Dropping ‘Unnecessary’ Studies
US Industry Association Calls For ‘Streamlining’ Of FDA Approval Process For Biosimilars
Jun 03 2024
•
By
Dave Wallace
“The time is now to update and streamline the current regulatory model for biosimilars,” according to the AAM's Biosimilars Council • Source: Shutterstock
More from Biosimilars
More from Products